Literature DB >> 22221439

Serum 25-hydroxyvitamin D is associated with enhanced pneumococcal antibody levels in individuals with asthma.

Jusuk Lee1, Hongxia Zhao, Yilma Fenta, Hirohito Kita, Rajiv Kumar, Young J Juhn.   

Abstract

Recent studies suggest that vitamin D modulates innate immunity and reduces the risk of microbial infections. Little is known about the role of vitamin D in antipneumococcal immunity in individuals with asthma. We determined the correlation between serum 25-hydroxyvitamin D (25[OH]D) levels and pneumococcal antibody levels in individuals with asthma, atopic dermatitis, or allergic rhinitis, and atopic sensitization status. A cross-sectional study was conducted for 21 subjects with asthma and 23 subjects without asthma. Pearson's correlation coefficient between serum 25(OH)D concentrations and the number of positive serotype-specific antibody levels was calculated among individuals with and without asthma, atopic dermatitis, and/or allergic rhinitis and atopic sensitization status. The overall correlation between serum 25(OH)D concentrations and positive pneumococcal antibody levels in all subjects regardless of asthma was not significant (r = -0.14; p = 0.38). Stratified analysis results showed that there was a positive correlation between serum 25(OH)D concentrations and positive pneumococcal antibody levels in asthmatic patients (r = 0.45; p < 0.05) and an inverse correlation was observed in nonasthmatic patients (r = -0.53; p < 0.05). These trends were similar for subjects with and without atopic dermatitis and/or allergic rhinitis (r = 0.58 and p = 0.008 versus r = -0.63 and p = 0.001). Despite similar trends in the correlation between serum 25(OH)D and pneumococcal antibody concentrations among those with and without atopic sensitization status (r = 0.27 and p = 0.19 versus r = -0.41 and p = 0.08), they did not reach statistical significance. The 25(OH)D may enhance humoral immunity against Streptococcus pneumonia in subjects with atopic conditions but not without atopic conditions. Atopic conditions may have an important effect modifier in the relationship between serum 25(OH)D concentrations and immune function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22221439      PMCID: PMC5565150          DOI: 10.2500/aap.2011.32.3494

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  45 in total

1.  The role of vitamin D in asthmatic children.

Authors:  Marianne Frieri
Journal:  Curr Allergy Asthma Rep       Date:  2011-02       Impact factor: 4.806

2.  Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin.

Authors:  Philip T Liu; Steffen Stenger; Dominic H Tang; Robert L Modlin
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

3.  Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response.

Authors:  Philip T Liu; Steffen Stenger; Huiying Li; Linda Wenzel; Belinda H Tan; Stephan R Krutzik; Maria Teresa Ochoa; Jürgen Schauber; Kent Wu; Christoph Meinken; Diane L Kamen; Manfred Wagner; Robert Bals; Andreas Steinmeyer; Ulrich Zügel; Richard L Gallo; David Eisenberg; Martin Hewison; Bruce W Hollis; John S Adams; Barry R Bloom; Robert L Modlin
Journal:  Science       Date:  2006-02-23       Impact factor: 47.728

4.  No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects.

Authors:  Rolf Jorde; Monica Sneve; Peter A Torjesen; Yngve Figenschau; Lasse G Gøransson; Roald Omdal
Journal:  Cytokine       Date:  2010-02-01       Impact factor: 3.861

Review 5.  Impact of micronutrients on respiratory infections.

Authors:  Christopher E Taylor; Carlos A Camargo
Journal:  Nutr Rev       Date:  2011-05       Impact factor: 7.110

6.  A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections.

Authors:  M Li-Ng; J F Aloia; S Pollack; B A Cunha; M Mikhail; J Yeh; N Berbari
Journal:  Epidemiol Infect       Date:  2009-03-19       Impact factor: 2.451

7.  An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men.

Authors:  Ilkka Laaksi; Juha-Petri Ruohola; Pentti Tuohimaa; Anssi Auvinen; Riina Haataja; Harri Pihlajamäki; Timo Ylikomi
Journal:  Am J Clin Nutr       Date:  2007-09       Impact factor: 7.045

8.  1,25-Dihydroxyvitamin D3 prevented allergic asthma in a rat model by suppressing the expression of inducible nitric oxide synthase.

Authors:  Yan Zhou; Xin Zhou; Xiaoqiu Wang
Journal:  Allergy Asthma Proc       Date:  2008 May-Jun       Impact factor: 2.587

9.  Increased risk of serious pneumococcal disease in patients with asthma.

Authors:  Young J Juhn; Hirohito Kita; Barbara P Yawn; Thomas G Boyce; Kwang H Yoo; Michaela E McGree; Amy L Weaver; Peter Wollan; Robert M Jacobson
Journal:  J Allergy Clin Immunol       Date:  2008-09-13       Impact factor: 10.793

Review 10.  High prevalence of vitamin D inadequacy and implications for health.

Authors:  Michael F Holick
Journal:  Mayo Clin Proc       Date:  2006-03       Impact factor: 7.616

View more
  4 in total

1.  Relatively high serum vitamin D levels do not impair the antibody response to encapsulated bacteria.

Authors:  E Peelen; G Rijkers; A Meerveld-Eggink; S Meijvis; M Vogt; J W Cohen Tervaert; R Hupperts; J Damoiseaux
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-09       Impact factor: 3.267

2.  Serum 25-hydroxyvitamin D concentrations and waning pneumococcal antibody titers among individuals with atopy.

Authors:  Eell Ryoo; Rajiv Kumar; Hirohito Kita; Young J Juhn
Journal:  Allergy Asthma Proc       Date:  2013 Jul-Aug       Impact factor: 2.587

Review 3.  Risks for infection in patients with asthma (or other atopic conditions): is asthma more than a chronic airway disease?

Authors:  Young J Juhn
Journal:  J Allergy Clin Immunol       Date:  2014-08       Impact factor: 10.793

Review 4.  Vitamin D in asthma and future perspectives.

Authors:  Haidong Huang; Konstantinos Porpodis; Paul Zarogoulidis; Kalliopi Domvri; Paschalina Giouleka; Antonis Papaiwannou; Stella Primikyri; Efi Mylonaki; Dionysis Spyratos; Wolfgang Hohenforst-Schmidt; Ioannis Kioumis; Konstantinos Zarogoulidis
Journal:  Drug Des Devel Ther       Date:  2013-09-23       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.